Clinical Trials Logo

Shift-Work Sleep Disorder clinical trials

View clinical trials related to Shift-Work Sleep Disorder.

Filter by:

NCT ID: NCT00078312 Completed - Clinical trials for Sleep Apnea, Obstructive

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the safety and tolerability of Armodafinil (CEP-10953) administered on a flexible-dosage regimen of 100 to 250 mg/day for up to 12 months to patients with excessive sleepiness associated with a current diagnosis of narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS)(regular users of nasal continuous positive airway pressure [nCPAP] therapy), or chronic shift work sleep disorder (SWSD).